Voyager Therapeutics (VYGR) EBITDA Margin Growth (5y) (2020 - 2026)
Voyager Therapeutics (VYGR) EBITDA Margin Growth (5y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Voyager Therapeutics | 183.84 Mn | 42.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -77,376.00 |
| Dec 31, 2025 | 16,830.00 |
| Sep 30, 2025 | -30,064.00 |
| Jun 30, 2025 | -67,301.00 |
| Mar 31, 2025 | -40,073.00 |
| Dec 31, 2024 | -56,569.00 |
| Sep 30, 2024 | 3,120.00 |
| Jun 30, 2024 | -7,074.00 |
| Mar 31, 2024 | 48,066.00 |
| Dec 31, 2023 | 121,343.00 |
| Sep 30, 2023 | 37,038.00 |
| Jun 30, 2023 | 47,893.00 |
| Mar 31, 2023 | 232,083.00 |
| Dec 31, 2022 | 177,927.00 |
| Sep 30, 2022 | 206,956.00 |
| Jun 30, 2022 | -113,648.00 |
| Mar 31, 2022 | -204,782.00 |
| Dec 31, 2021 | 60,638.00 |
| Sep 30, 2021 | -138,325.00 |
| Jun 30, 2021 | -184,794.00 |